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 Kinin B1 receptor gene ablation affects 
hypothalamic CART productionb 
 Abstract:  A role for the kinin B1 receptor in energy-homeo-
static processes was implicated in previous studies; nota-
bly, the studies where kinin B1 receptor knockout mice 
(B1 -/- ) were shown to have impaired adiposity, impaired 
leptin and insulin production, lower feed efficiency, pro-
tection from liver steatosis and diet-induced obesity when 
fed a high fat diet (HFD). In particular, in a model where 
the B1 receptor is expressed exclusively in the adipose tis-
sue, it rescues the plasma insulin concentration and the 
weight gain seen in wild type mice. Taking into conside-
ration that leptin participates in the formation of hypo-
thalamic nuclei, which modulate energy expenditure, 
and feeding behavior, we hypothesized that these brain 
regions could also be altered in B1 -/- mice. We observed for 
the first time a difference in the gene expression pattern 
of cocaine and amphetamine related transcript (CART) in 
the (lateral hypothalamic area (LHA) resulting from the 
deletion of the kinin B1 receptor gene. The correlation 
between CART expression in the LHA and the thwarting 
of diet-induced obesity corroborates independent correla-
tions between CART and obesity. Furthermore, it seems to 
indicate that the mechanism underlying the  ‘ lean ’ phe-
notype of B1 -/- mice does not stem solely from changes 
in peripheral tissues but may also receive contributions 
from changes in the hypothalamic machinery involved in 
energy homeostasis processes. 
 Keywords:  hypothalamus;  kinin B1 receptor;  knockout 
mice;  lateral hypothalamic area. 
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 Introduction 
 The kallikrein-kinin system is a complex molecular sign-
aling network in which kinin peptides are cleaved from 
kininogen precursors by the kallikrein serine proteases 
and then activate a set of two G-protein coupled receptors 
denominated B1 and B2. These receptors in turn trigger 
distinct intracellular signal transduction cascades, which 
are classically correlated to effects on blood pressure, 
nociception and inflammation systems (for a compre-
hensive review see Moreau et  al. , 2005 ). Contrary to the 
B2 kinin receptor, whose expression is constitutive, the B1 
receptor is mostly expressed in inflammatory conditions 
in response to tissue injury (Prado et al. , 2002 ). 
 In addition to these more classically associated physi-
ological functions, the kallikrein-kinin system has also 
been implicated in processes of homeostasis of energy, 
such as glucose uptake and insulin responsiveness (Beard 
et  al. , 2006 ). A role of the B1 receptor in metabolic pro-
cesses was suggested by observations that animal models 
of insulin-dependent diabetes mellitus were protected 
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from hyperglycemia, insulitis and renal damage when 
treated with a B1 antagonist (Zuccollo et al. , 1999 ). While 
these early findings implicate a contribution for the B1 
receptor in energy balance mechanisms, the exact meta-
bolic processes involved could be shoown in more detail 
with further exploration of the B1 knockout (B1 -/- ) phe-
notype. Ara ú jo et  al. (2006) verified that B1 -/- mice have 
pancreatic abnormalities, such as fewer islets of Langer-
hans and lower glucose-triggered insulin release. They 
also observed that the endogenous B1 agonist des-Arg9-
bradykinin (DBK) stimulates insulin release  in vivo in wild 
type mice by increasing pancreatic vascular permeability 
(Ara ú jo et al., 2006 ). 
 Notably, Mori et  al.  (2008b) verified that B1 -/- mice 
are completely resistant to obesity induced by a high fat 
diet (HFD) (e.g., a  ‘ lean ’ phenotype). A set of experiments 
were designed to investigate a putative influence of the B1 
receptor in the homeostasis of leptin (Mori et al. , 2008a ), 
a 16 kDa cytokine produced by adipocytes that has a major 
role in the induction of satiety. The  in vivo results showed 
a clear positive effect of DBK on serum leptin levels in wild 
type mice, but no effect whatsoever was seen in leptin 
secretion by wild type adipocytes cultured  in vitro (Mori 
et al. , 2008a ). Taken together these observations suggest 
that the DBK-triggered increased leptin production cannot 
be accounted for by a direct mechanism alone, where 
DBK would bind B1 receptors on adipocytes and initi-
ate a signal transduction cascade, culminating in leptin 
secretion. Recently our group has shown that leptin also 
plays an important role in the liver lipid metabolism in 
B1 -/- animals. These animals showed a reduction in hepatic 
lipogenesis and steatosis after HFD, possibly through a 
SCD-1 dependent mechanism (Fonseca et al. , 2013 ). 
 The task of coordinating metabolic processes across 
the entire body is fulfilled by the central nervous system. 
In particularl, signals conveying information from differ-
ent sources of currently available and stored fuels con-
verge in the hypothalamus. At that portion of the brain 
metabolic status signals are integrated and may further 
affect leptin secretion by adipocytes (Cota et al. , 2007 ). 
 In that regard, the arcuate nucleus (ARC) plays an 
important role, as it has a high density of leptin recep-
tors (Ob-Rb) and the modified blood-brain-barrier (e.g., 
no tight-junctions at the median eminence; Norsted et al. , 
2008 ), which allows the passage of leptin and insulin. 
The ARC neurons can be categorized into orexigenic and 
anorexigenic. The orexigenic population synthesizes 
the neuroactive compounds neuropeptide Y (NPY) and 
agouti-related peptide (AgRP) and promotes the gain of 
body mass. The anorexigenic population synthesizes pro-
opiomelanocortin (POMC) and cocaine and amphetamine 
related transcript (CART) and promotes weight loss when 
stimulated by leptin (Williams et al. , 2001 ). In fact, many 
of the anorexigenic effects of leptin are related to neuron 
projections stemming from the ARC to other hypothalamic 
regions, such as the paraventricular nucleus (PVH) and 
the lateral hypothalamic area (LHA), each of which par-
ticipates in distinct ways in the control of feeding behavior 
and energy expenditure (Bouret and Simerly , 2007 ). In the 
ARC, leptin increases the frequency of action potentials in 
CART/POMC neurons (Cowley et al. , 2001 ) and also inhi-
bits NPY/AgRP neurons, reduces appetite and increases 
metabolism. 
 It was recently shown that kinin B1 receptor ablation 
affects adipogenesis, resulting in reduced number and 
volume of adipocytes (Mori et  al. , 2008b ), which have 
a major role in leptin secretion in the body. As a conse-
quence, serum leptin levels are diminished in B1 -/- mice. 
As we know that leptin has a role in modulating the matu-
ration of the hypothalamus (Simerly , 2008 ), we could 
expect that lowered serum leptin levels would lead to an 
anomalous hypothalamus. Evidence for the neurotrophic 
role of leptin was reported as abnormal wiring of hypotha-
lamic circuits in mice models of severe obesity (ob/ob) in 
which leptin signaling is absent. Transient restoration of 
fiber density (Bouret et al. , 2004 ) and number of synapses 
(Pinto et al. , 2004 ) is achieved with leptin treatment. 
 In this work we hypothesized that the B1 -/-  ‘ lean ’ phe-
notype might be related to changes in gene expression 
patterns in fuel-state-sensing hypothalamic nuclei and 
tried to verify the hypothesis by semi-quantitatively com-
paring the local expression levels of NPY and CART in the 
hypothalamus of B1 -/- and wild type (WT) mice. 
 Results 
 There is no difference in NPY mRNA 
 expression level in B1 -/- 
 In the hypothalamus NPY is expressed in neurons in the 
ARC. These neurons project their axons mainly to the PVH 
and adjacent perifornical area of the LHA, there promot-
ing a positive state of energy balance by increasing energy 
intake and decreasing energy expenditure as well as stimu-
lating lipogenesis (as reviewed by Woods et al. , 1998 ). In 
order to investigate a possible NPY-dependent mechanism 
that contributes to the lean phenotype seen in the B1 -/- , 
the NPY mRNA expression was elected for measurement 
in the ARC by  in situ hybridization (ISH). The NPY mRNA 
hybridization signal was intense at a portion of the ARC 
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 Figure 1   NPY mRNA expression in the ARC. 
 (A) Representative photomicrographs showing the NPY 
mRNA hybridization probe distribution across the ARC. Scale 
bars = 200  μ m. 3v, third ventricle; ARC, arcuate nucleus. (B) 
Semiquantitative comparison of NPY mRNA expression. Data are 
expressed as mean ± SEM (n = 5 WT and 5 B1 -/- ). IOD, integrated 
optical density. 
nucleus closer to the median eminence and the third ven-
tricle (Figure  1 A). The NPY mRNA expression level at this 
region in the ARC was not different between the groups of 
B1 -/- and WT mice (Figure 1B). 
 Increased CART expression in B1 -/- LHA 
 It has been reported that the CART-expressing neuron 
population in the ARC has projections adjacent to those of 
the NPY-expressing neurons and seem to exercise the con-
trary physiological function, i.e., to quench the appetite 
and promote energy expenditure (Vrang , 2006 ). Once the 
NPY neurons (Figure 1) are not altered in B1 -/- , we hypoth-
esized that the CART neurons may be acting to promote 
the lean phenotype of B1 -/- . The CART mRNA expression 
level in the ARC nucleus seems to be the same in both 
groups, as revealed by ISH (Figure  2 A and B). The PVH, in 
addition to containing CART-expressing neurons, receives 
input from anorexigenic populations such as those in the 
ARC. The neuron population of this nucleus is quite het-
erogeneous, with distinct co-expression of several other 
molecules also implicated in the modulation of the energy 
balance (Vrang , 2006 ) and is thus a good candidate site 
for differential CART expression. Nevertheless, no signifi-
cant difference was observed between B1 -/- and WT mice 
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 Figure 2   CART mRNA expression in the ARC, PVH and LHA. 
 (A, C and E) Representative photomicrographs showing the CART mRNA hybridization probe distribution across the ARC, PVH and LHA 
respectively. Scale bars = 200  μ m. 3v, third ventricle; ARC, arcuate nucleus; fx, fornix; PVH, paraventricular nucleus; VMH, ventromedial 
nucleus. (B, D and F) Semiquantitative comparison of CART mRNA expression in the ARC, PVH and LHA respectively. Data are expressed as 
mean ± SEM (n = 5 WT and 5 B1 -/- ). * p < 0.05. IOD, integrated optical density. 
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CART mRNA expression in the PVH (Figure 2C and D). 
Numerous CART-expressing neurons are found dispersed 
across the LHA with a distinctly higher density in the peri-
fornical area (PeF) (Elias et al. , 2001 ; Vrang , 2006 ). This 
region was elected for investigation in B1 -/- mice and a 
higher CART mRNA level was present in this group when 
compared to the CART expression levels of the control 
group (Figure 2E and F). The quantification of the CART 
peptide was also performed by computer-assisted count-
ing of CART-immunoreactive cells inside a rectangular 
region of interest (see Methods) that contained the fornix 
(Figure  3 A). A greater mean number of CART-expressing 
cell-bodies was counted in the knockout group than in the 
WT group (Figure 3B). 
 Unchanged spontaneous locomotor activity 
in B1 -/- mice 
 Spontaneous locomotor activity was measured to verify 
whether the lean phenotype of B1 -/- mice was caused by or 
related to behavioral change. In this model, the amount of 
movement was similar in B1 -/- and WT mice in the light and 
in the dark cycle (Figure  4 ). 
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 Figure 4   Spontaneous locomotor activity in WT and B1 knockout 
mice (n = 10 WT and B1 -/- ). 
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 Figure 3   CART peptide expression in the LHA. 
 (A) Representative photomicrographs showing the CART immunore-
activity across the LHA. Scale bars  = 200  μ m. fx, fornix. (B) Quantita-
tive comparison of CART-expressing cells. Data are expressed as 
mean ± SEM (n = 5 WT and 5 B1 -/- ). * p < 0.05. 
 Discussion 
 As shown previously (Mori et al. , 2008b ), the mean body 
weight of B1 -/- mice and WT mice are not significantly dif-
ferent when fed a regular chow diet. Surprisingly, when 
fed a HFD B1 -/- diet mice remain lean while the WT mice 
become obese (Mori et  al. , 2008b ). When the kinin B1 
receptor is expressed exclusively in the adipose tissue, 
the plasma insulin level is restored, as is the weight gain 
after HFD, but no change is seen in leptin levels (Mori 
et al. , 2012 ). Kinin B1 receptor antagonism in rats is able to 
reduce plasma levels of insulin, glucose, and reverses the 
enhancing effect of glucose feeding on whole body and 
epididymal fat mass and on the expression of inflamma-
tory markers in retroperitoneal adipose tissue and aorta 
(Dias and Couture , 2012a,b ). In those same models, the B1 
antagonist also reversed B1R overexpression in the spinal 
cord, aorta, liver and gastrocnemius muscle and the 
high blood pressure in a dose-dependent manner, acting 
through a NADPH depend pathway (Dias et  al. , 2010 ). 
Interestingly, these authors did not observe changes in 
the circulating levels of leptin after treatment with kinin 
B1 receptor antagonist. 
 It has been shown that deletion of one kinin receptor 
could lead to the modulation of the other kinin receptor 
expression (Duka et al. , 2008 ; Marcon et al. , 2013 ). There-
fore, the theory could be profered that the kinin B2 recep-
tor could be compensating for the lack of the kinin B1 
receptor. However, in our model, we measured the mRNA 
expression of kinin B2 receptor in total hypothalamus and 
it was not different in comparison to the control animal 
(data not shown). 
 In this sense, the genetic or the pharmacological 
models for targeting the kinin B1 receptor have shown 
the importance of this receptor in energy-metabolism; 
however the mechanisms involved are still largely 
unknown. Our group has already demonstrated that the 
mechanism might be linked to the regulation of Ob-Rb 
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receptors involved in the signaling of the weight control-
ling hormone leptin (Mori et al. , 2008b ). We hypothesized 
that hypothalamic wiring abnormalities caused by the dif-
ferential expression of energy-metabolism neuromodula-
tors in the hypothalamus of B1 -/- mice that could contribute 
to their  ‘ lean ’ phenotype might exist. Therefore we chose 
to evaluate the expression of metabolism-related neuro-
modulators locally, in specific hypothalamic nuclei. Our 
measurements show a higher density of CART mRNA and 
CART-immunoreactive cells in the PeF area of the LHA, 
which could contribute to the  ‘ lean ’ phenotype. 
 At the LHA, CART is known to be co-expressed with 
melanin concentrating hormone (MCH), a neuropeptide 
that has an orexigenic role at this area  – a paradox that 
might be resolved by the hypothesis raised by Vrang and 
collaborators that CART is not anorexigenic at this site and 
may be involved in other physiological processes (Vrang , 
2006 ). 
 The sending of inputs from CART-expressing neurons 
to the ventral tegmental area (VTA)  – a component of the 
mesolimbic system  – suggests a role in the modulation of 
reward and reinforcement systems that control motiva-
tional behavior (Philpot et al. , 2005 ). Furthermore, most 
drugs causing drug addiction act by increasing dopa-
mine release in the mesolimbic circuit, interfering with 
the normal functioning of this ancient reward system; 
the wiring of which has evolved to control  – among other 
things  – food-seeking behavior, which in turn impacts 
every other behavior involving energy expenditure (for a 
review focusing on the role of reward in feeding and appe-
tite the reader is referred to Fulton , 2010 ). 
 In the VTA in particular, the CART peptide seems to 
act as a potent stimulator of locomotor activity and con-
ditioned place preference (Jaworski et al. , 2003, 2007 ), a 
form of Pavlovian conditioning also elicited by addictive 
drugs (Tzschentke , 1998 ). It is thought that the behavio-
ral effects of CART activity in the VTA occur by CART 
directly stimulating dopaminergic neurons or indirectly 
un-inhibiting gamma-amino-butyric-acid-ergic interneu-
rons (Kuhar et al. , 2005 ). A facilitated capacity to reduce 
dopamine availability could counter the feeding reward 
effect, and contribute to diet-induced-obesity resistance 
in B1 -/- mice. 
 It seemed plausible that the increased mean number 
of CART-producing cells in the PeF of B1 -/- mice would pre-
sumably cause increased CART stimulation in the VTA 
and consequent increased basal locomotor  activity in 
compari son to WT counterparts. Higher locomotor acti-
vity in turn could lead to less energy accumulation in fat 
stores and contribute to the  ‘ leaner ’ B1 phenotype. It was 
observed, however, with the method we applied that the 
B1 -/- mice do not move significantly more than control mice 
in normal circumstances of chow diet. As the  ‘ lean ’ phe-
notype is observed only when these mice are challenged 
with a HFD, it could be the case that differences in loco-
motor activity also only take place under HFD, a hypoth-
esis that remains untested. 
 In B2 -/- animals, it was seen during aging that they did 
not increase the consolidation and retention of memory 
after a learning challenge, but that was not the case in 
B1 -/- (Lemos et al. , 2010 ). This suggests that kinin B2 recep-
tor activity might contribute to efficient learning behavior 
and an increase in locomotor activity. A second important 
point is that it could be expected because the  ‘ lean ’ pheno-
type is observed only when these mice are challenged with 
a HFD. HFD seems to promote increased energy expendi-
ture and lower feed efficiency (body weight gain/energy 
consumed) in B1 -/- in comparison to WT mice as revealed 
per calorimetric observations (Mori et al. , 2008b ). In fact, 
it is known that HFD increases 30% the CART expression 
in hypothalamic tissue extracts (Lee et al. , 2010 ), presum-
ably as a compensatory mechanism to maintain body 
weight. One hypothesis is that in B1 -/- model the machinery 
could be prepared with higher amount of CART neurons in 
the LHA but its effects are not required under basal con-
ditions, probably because of its compensatory increased 
respiratory coefficient (Mori et al. , 2008b ). 
 The finding that genetic manipulation of B1 receptors 
affects CART neurons comes as a surprise and seems to 
indicate there is a gene-regulatory coupling between these 
gene systems. We believe that the B1 gene ablation dis-
turbs the CART-mediated energy expenditure adaptation 
mechanism that exists in WT mice, allowing them to gain 
weight in conditions of HFD. 
 The idea that CART has a role in the B1 -/-  ‘ lean ’ phe-
notype seems likely in the face of knowledge that CART 
expression is reduced in situations where energy expendi-
ture is decreased, as discussed in a recent study in which a 
screening for genetic influences on energy expenditure of 
obese individuals was performed (Goossens et al. , 2009 ). 
 The data presented in this work show for the first 
time a change in the LHA-CART expression related to a 
diet-induced-obesity resistance phenotype and seems 
to corroborate previous indications that CART is not a 
solely anorectic peptide in the hypothalamus. The obser-
vations here also corroborate previous indications that 
the B1-receptor-triggered mechanism impinging on body 
weight is not (solely at least) peripheral. 
 Future work should investigate putative gene- 
regulatory relationships between the kinin B1 receptors 
and pro-energy expenditure CART neuropeptides in the 
hypothalamus and mesolimbic systems. In addition, it 
906      H.A.M. Torres et al.: Kinin B1 receptor modulates CART expression
is important to analyze the axonal projection neurons to 
ensure its importance. Finally, the study furthers the pos-
sibility that B1 receptor might be useful as target for anti-
obesity drug development, as supported by many previous 
works. 
 Material and methods 
 Animals 
 Data were obtained from 14-week-old male kinin B1 receptor knock-
out mice produced by Pesquero et al.  (2000) and C57BL/6 WT con-
trol mice bred at Universidade Federal de S ã o Paulo, Brazil. The 
investigation conforms to  The Guide for the Care and Use of Labora-
tory  Animals (U.S. NIH , 1996 ). Animals were maintained on standard 
mouse chow at 22 ° C on a 12-h light-dark cycle with  ad libitum access 
to food and tap water. Body weights were measured directly before 
the animals were sacrifi ced. 
 Brain preparation 
 Mice were deeply anesthetized with a solution containing ketamine 
(80 mg/kg) and xylazine (30 mg/kg) and perfused intracardially with 
a 0.9% saline solution and followed by a formaldehyde solution 
(4% m/v) in 0.01  m phosphate buff er (PBS). The heads were removed 
and kept in the formaldehyde solution for 24 h at room temperature. 
Later, the brains were removed from the skulls and maintained in 
the formaldehyde solution for an additional 12 h. Brains destined for 
immunohistochemistry were used from this point. Brains destined 
for  ISH were postfi xed in cryoprotectant solution (20% sacharose and 
4% formaldehyde) at 4 ° C for 12 h before proceeding. 
 In situ hybridization 
 Coronal sections of formaldehyde-preserved brains were cut with 
a microtome at 30  μ m thickness, preserved in cryoprotectant and 
stored at -70 ° C.  In situ hybridization for CART and NPY mRNA was 
performed as reported by Elias et al.  (1998) in a single batch. One of 
every third section was mounted and used for probe hybridization. 
The respective [ 35 S] riboprobes were generated as described previous-
ly and kindly provided by Dr. Jackson Cioni Bittencourt ’ s lab: CART 
(Douglass et al. , 1995 ; Elias et al. , 2000 ; Borges et al. , 2007 ) and NPY 
(Higuchi et  al. , 1988 ; Borges et  al. , 2007 ). Briefl y, the probes were 
 in vitro transcribed with the appropriate RNA polymerases (either T3 
or SP6) according to the producer ’ s protocol (Promega). 
 [ 35 S]cDNA probes for each mRNA was diluted to 106 cpm/ml in 
hybridization solution (50% formamide, 10 m m Tris-HCl, pH 8.0, 10 
m m dithiotreitol (DTT), 10% dextran sulphate, 0.3  m NaCl, 1 m m EDTA 
pH 8.0 and Denhardt ’ s solution (Invitrogen). Brain sections were incu-
bated with a hybridization solution fi lm applied between each glass 
slide and a fl exible coverslip for 16 h at 57 ° C in a hybridization oven. 
Sections were then incubated in 0.002% RNAse A with 0.5  m NaCl, 
10 m m Tris-HCl, pH 8.0 and 1 m m EDTA for 30 min. Subsequently, sec-
tions were washed in decreasing concentrations of SSC containing 
0.25% DTT (2-SSC at 50 ° C for 1 h, 0.2-SSC at 55 ° C for 1 h and 0.2-SSC at 
60 ° C for 1 h). Sections were then dehydrated in 70% ethanol contain-
ing 0.25% DTT for 10 min. Slides were air-dried and placed into  X-ray 
fi lm cassettes with BMR-2 fi lm (Kodak, Rochester, NY) for 20 days. 
Slides were then dipped into NTB2 photographic emulsion (Kodak), 
dried and stored in boxes with desiccating  pellets and foil-wrapped 
boxes at 4 ° C for 2 weeks. Finally, slides were  developed with D-19 
 developer (Kodak), at 15 – 16 ° C for 1 min,  counterstained with thionin, 
dehydrated in graded ethanol concentrations, cleared in xylene and 
coverslipped with Permaslip. 
 Immunohistochemistry 
 Thirty  μ m coronal sections of formaldehyde-preserved brains were 
cut in a vibration microtome (Leica VT1000 S) and kept in anti-
freeze solution (90 m m saccharose, 50 m m sodium PBS, 2.5 m m poly-
vinilpyrrolidone (PVP)-40 (Sigma) and 30% v/v etylene glycol) at 
-20 ° C. All further processing was carried out in one batch, i.e., every 
third section of mice brain was exposed to identical buff er, antibody 
and chromogenic solutions in order to minimize possible variables. 
 The protocol was established based on preliminary assays on 
antibody titration and incubation conditions. The anti-CART rabbit 
immunoglobulin (Phoenix Pharmaceuticals) optimal dilution was 
1:20,000. All the steps were carried out in the free-fl oating mode on 
an orbital shaker according to the streptavidin-biotin-peroxidase 
method. 
 Aft er rinsing, sections labeled with primary antibodies were 
incu bated for 10  min at room temperature in secondary-antibody 
solution (a biotinylated anti-mouse, goat and rabbit antibody from 
DAKO LSAB TM Universal Kit). 
 Image acquisition and semiquantitative 
analysis 
 The ISH photomicrographs were captured with a SPOT RT  ®  digital 
camera (Diagnostic Instruments Sterling Heights, MI, USA), adapted 
to a Leica DMR microscope (Leica, Wetzlar, Germany) and the Nis-
Elements 3.0 program (Nikon Corporation, Melville, NY). All digital 
image processing was read double-blind (fi lenames were assigned a 
single random number by a Python program in order for the experi-
mental group to be unknown to the researcher). The hybridization 
signal was estimated by double-blind comparison of the integrated 
optical density (IOD; mean pixel intensity on a gray scale ranging 
from 0 to 255 multiplied by area) in a constant area of three repre-
sentative rostrocaudal levels of each nucleus, matched as closely as 
possible according to the atlas of Paxinos and Franklin  (2001) . 
 Analysis of spontaneous locomotor activity 
 Mice spontaneous locomotor activity was measured during the day 
(9  am) and at night (9 pm) using Opto-Varimex photocell cages 
( Columbus, OH, USA), which read motion by interpreting adjacent 
infrared light-bean disruption as horizontal movement. Prior to the 
experiments, mice were habituated to the room for 1  h and then 
placed into the activity chambers for 30-min measurement sessions. 
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 Statistical analysis 
 Data were expressed as mean ± SEM of integrated optical densities. 
Diff erences between groups were analyzed using either two-tailed 
unpaired Student ’ s t-test (when analyzing two groups) and two-way 
ANOVA and Bonferroni ’ s  post hoc test in the spontaneous locomotor 
activity experiment. Signifi cance was rejected when  p > 0.05. All sta-
tistical analyses were carried out with the Graphpad Prism (La Jolla, 
CA, USA) soft ware package. 
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